Loading the section
Company reports as filed with the U.S. Securities and Exchange Commission.
| Metric | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 |
|---|---|---|---|---|
| Research and development | 6m | 11m | 18m | 17m |
| Selling, general and administrative | 4m | 3m | 7m | 12m |
| Operating expenses | 10m | 15m | 25m | 29m |
| Pre-tax income | −9m | −14m | −24m | −28m |
| Income tax | 0 | 0 | 0 | −534,000 |
| Net income | −9m | −14m | −24m | −28m |
| Earnings per share | 0.02 | 0.04 | 0.10 | 0.12 |
| Earnings per share, diluted | 0.02 | 0.04 | 0.10 | 0.12 |
| Weighted average shares | 510m | 359m | 235m | 228m |
| Weighted average shares, diluted | 510m | 359m | 235m | 228m |
| Metric | Aug 18, 2026 | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 |
|---|---|---|---|---|---|---|
| Cash and equivalents | — | 8m | 6m | 9m | 14m | 15m |
| Current assets | — | 13m | 16m | 21m | — | — |
| Property, plant and equipment | — | 176,000 | 250,000 | 303,000 | — | — |
| Total assets | — | 14m | 17m | 22m | — | — |
| Current liabilities | — | 1m | 3m | 5m | — | — |
| Total liabilities | — | 1m | 3m | 5m | — | — |
| Equity | — | 12m | 14m | 17m | 36m | 61m |
| Shares outstanding | — | 575m | 377m | 284m | — | — |
| Shares issued | — | 575m | 377m | 284m | — | — |
| Metric | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 |
|---|---|---|---|---|
| Operating cash flow | −11m | −15m | −24m | −20m |
| Depreciation and amortisation | 70,000 | 53,000 | 67,000 | 58,000 |
| Share-based compensation | 623,000 | 617,000 | 1m | 3m |
| Capital expenditure | 3,000 | 0 | 3,000 | 68,000 |
| Investing cash flow | 5m | 2m | 16m | 20m |
| Financing cash flow | 7m | 10m | 4m | −808,000 |
Amounts in USD unless stated otherwise. Sources: Nasdaq Trader, Yahoo Finance, U.S. Securities and Exchange Commission (EDGAR)